DeciBio
Ben Yarovinsky is a Life Science Analyst at DeciBio since September 2023. Prior to this role, Ben was a Neurosurgery Clinical Research Assistant at the University of California, San Francisco and Keck Medicine of USC from 2021 to 2023. Ben also worked as a Business Strategy and Operations intern at Catena Biosciences. Ben holds a Bachelor of Science in Business Administration and Management from the University of California, Berkeley and a Bachelor of Arts in Cell/Cellular and Molecular Biology.
This person is not in the org chart
DeciBio
1 followers
DeciBio Consulting is a boutique strategy consulting firm focusing on the life science industry. DeciBio's mission is to provide the strategic insights that accelerate the development, adoption, and accessibility of personalized medicine. Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 life science corporations. DeciBio addresses business solutions that range from market landscape analyses to full commercial strategies, including organic and inorganic growth opportunities (commercial due diligences). DeciBio’s work is typically supported by a mix of primary and secondary research leveraging Dexter, its in-house expert network, and DeciBio Analytics’ proprietary data intelligence products. DeciBio’s Analytics division offers numerous data products to support strategic insights, including in clinical diagnostics (the DxBooks), immuno-oncology (the I/O BioMAP), omics market segmentation (the MarketBooks), and the entire life sciences industry (BioTrack). Internal teams such as the Culture Committee, Women* in Consulting, and Gays in Consulting enrich the employee experience. DeciBio’s Social Impact board and the DeciBio Impact Lab work collaboratively across divisions and externally to uproot discrimination and increase access to precision medicine.